Thyme Care
Nashville, US · Founded 2020 · Delaware corporation · 8 known investors
Thyme Care develops software to enhance care coordination and outcomes for cancer patients. The platform serves oncology practices and healthcare systems managing the cancer patient journey.
Founders & leadership
.jpg)
Investors · 8
AlleyCorpNew York · $1M – $5Mvia Brenton Fargnoli · board
Andreessen HorowitzMenlo Park · $500K – $50Mvia Vineeta Agarwala · board
Corewell Health VenturesGrand Rapids
CVS Health VenturesWoonsocket
Echo Health VenturesDurham
Foresite CapitalLarkspur
Frist Cressey VenturesNashville · $500K – $20M
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
Reported raises · per SEC filings
Form D private placements▶$97MraisedSep 2025 · 14 investors · Other Health CareRule 506(b)
▶$97MraisedSep 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David WhelanDirector
- Bradford DiephuisExecutive Officer
- Robert GreenExecutive Officer, Director
- Brian BelskyDirector
- Michael MarkowiczExecutive Officer
- Vivek GaripalliDirector
- Vineeta AgarwalaDirector
- Elizabeth CanisDirector
- Robin ShahExecutive Officer, Director
- Vijay PatelDirector
- Brenton FargnoliDirector
- Puneet SinghDirector
- Jesse WaldronExecutive Officer
- Offering amount
- $100M
- Amount sold
- $97M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$54.5MraisedJul 2024 · 13 investors · Other Health CareRule 506(b)
▶$54.5MraisedJul 2024 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian BelskyDirector
- Elizabeth CanisDirector
- Brenton FargnoliDirector
- Vineeta AgarwalaDirector
- Robert GreenExecutive Officer, Director
- Robin ShahExecutive Officer, Director
- Puneet SinghDirector
- Vivek GaripalliDirector
- Vijay PatelDirector
- David WhelanDirector
- Offering amount
- $54.5M
- Amount sold
- $54.5M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$49MraisedAug 2023 · 13 investors · Other Health CareRule 506(b)
▶$49MraisedAug 2023 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth CanisDirector
- Vineeta AgarwalaDirector
- David WhelanDirector
- Vivek GaripalliDirector
- Brenton FargnoliDirector
- Robin ShahExecutive Officer, Director
- Puneet SinghDirector
- Robert GreenExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $49M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$13.8MraisedNov 2021 · 10 investors · Other Health CareRule 506(b)
▶$13.8MraisedNov 2021 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Vineeta AgarwalaDirector
- Brenton FargnoliDirector
- Robin ShahExecutive Officer, Director
- Puneet SinghDirector
- Vivek GaripalliDirector
- Offering amount
- $18M
- Amount sold
- $13.8M
- Minimum investment
- $1
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Thyme Care: A Human Touch in Cancer Care, Guided by Technology | AJMCajmc.com · 2026
- Kevin Ryan’s AlleyCorp raises new $335 million fund, all in on early-stage bets | Fortunefortune.com · 2026
- Founder Of $1 Billion Cancer Care Startup Steps Down As CEOforbes.com · 2026
- Thyme Care garners $97M, achieves profitabilityblog.thymecare.com · 2025
- $97M Series D Backed by Strategic Investors Across the Oncology Ecosystem Positions Thyme Care to Break Through Cancer Care's Biggest Bottlenecksprnewswire.com · 2025
- Thyme Care Raises $97M in Series D Fundingfinsmes.com · 2025